HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

opicapone

structure in first source
Also Known As:
2,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine 1-oxide; BIA 9-1067; ongentys
Networked: 83 relevant articles (8 outcomes, 25 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Soares-da-Silva, Patrício: 21 articles (09/2022 - 01/2012)
2. Ferreira, Joaquim J: 13 articles (09/2022 - 01/2016)
3. Rocha, José-Francisco: 12 articles (09/2022 - 09/2014)
4. Rascol, Olivier: 11 articles (09/2022 - 01/2016)
5. Poewe, Werner: 8 articles (09/2022 - 01/2016)
6. Falcão, Amílcar: 8 articles (01/2017 - 01/2012)
7. Lees, Andrew: 7 articles (01/2022 - 01/2016)
8. Reichmann, Heinz: 6 articles (10/2022 - 07/2017)
9. Stocchi, Fabrizio: 4 articles (09/2022 - 07/2017)
10. Magalhães, Diogo: 4 articles (03/2022 - 01/2020)

Related Diseases

1. Parkinson Disease (Parkinson's Disease)
2. Dyskinesias (Dyskinesia)
3. Pain (Aches)
4. Constipation
5. Sleep Initiation and Maintenance Disorders (Insomnia)

Related Drugs and Biologics

1. Levodopa (L Dopa)
2. Catechol O-Methyltransferase (Methyltransferase, Catechol)
3. entacapone (Comtan)
4. Dopa Decarboxylase
5. Tablets
6. Carbidopa (Lodosyn)
7. 3-methoxytyrosine
8. Creatine Kinase (Creatine Phosphokinase)
9. Homocysteine
10. Benserazide

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)